Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Alise_Reicin
|
| gptkbp:focusesOn |
protein therapeutics
GPCR drug discovery |
| gptkbp:foundedIn |
2019
|
| gptkbp:founder |
gptkb:Andrew_Kruse
gptkb:Timothy_A._Springer |
| gptkbp:fundedBy |
gptkb:Omega_Funds
gptkb:Polaris_Partners gptkb:Eli_Lilly_and_Company gptkb:F-Prime_Capital GV (formerly Google Ventures) |
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tectonic Therapeutic
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
antibody therapeutics
structure-based drug design |
| gptkbp:website |
https://www.tectonictx.com/
|
| gptkbp:bfsParent |
gptkb:Mark_Leschly
|
| gptkbp:bfsLayer |
6
|